6533b870fe1ef96bd12d0608
RESEARCH PRODUCT
The T Cell Receptor (TCR) in HLA-B27-Restricted T Cell Responses - an Introduction
Elisabeth Märker-hermannK H Meyer Zum BüschenfeldeB. AckermannRainer DuchmannE. Maysubject
Cytotoxicity ImmunologicT cellT-cell receptorReceptors Antigen T-Cellhemic and immune systemschemical and pharmacologic phenomenaGeneral MedicineBiologyCTL*medicine.anatomical_structureRheumatologyAntigenRheumatic DiseasesImmunologymedicineCytotoxic T cellReceptorBeta (finance)HLA-B27 AntigenCD8description
Recent data indicate that cytotoxic T lymphocytes (CTL) are involved in the pathogenesis of HLA-B27-associated spondylarthropathies. In the absence of clearly defined "arthritogenic" bacterial or self peptides that are presented by HLA-B27 and recognized by such CD8+CTL, one approach has been to investigate the T cell repertoire of lesional cellular infiltrates by determining T cell receptor (TCR) variable (V) gene segment frequencies. Furthermore, the TCR V alpha and V beta chains of HLA-B27-restricted CTL clones, notably the putative peptide-contacting CDR3-regions of these TCRs, have been sequenced. This article will give a short review of the current literature on the topology of the TCR and its hypervariable CDR3 region, TCR repertoire diversity in rheumatic diseases and will concentrate on TCR V alpha and V beta gene usage in HLA-B27-restricted T cell responses.
year | journal | country | edition | language |
---|---|---|---|---|
1996-01-01 | Clinical Rheumatology |